Review ArticleReview

Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients

Wen-Ya Zhou, Hong Zheng, Xiao-Ling Du and Ji-Long Yang
Cancer Biology & Medicine June 2016, 13 (2) 260-268; DOI: https://doi.org/10.20892/j.issn.2095-3941.2015.0102

Article Information

vol. 13 no. 2 260-268
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2015.0102
Published By 
Cancer Biology & Medicine
History 
  • Received January 18, 2015
  • Accepted January 8, 2016
  • Published online June 1, 2016.
Copyright & Usage 
Copyright: © 2016, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Author Information

  1. Wen-Ya Zhou1,
  2. Hong Zheng2,
  3. Xiao-Ling Du3 and
  4. Ji-Long Yang1⇑
  1. 1Department of Bone and Soft Tissue Tumor
  2. 2Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China
  3. 3Department of Diagnostics, Tianjin Medical University, Tianjin 300061, China
  1. Correspondence to: Ji-Long Yang, E-mail: yangjilong{at}tjmuch.com
View Full Text

Cited By...

Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords